Filing Details
- Accession Number:
- 0001607062-18-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-22 13:28:21
- Reporting Period:
- 2017-11-13
- Accepted Time:
- 2018-03-22 13:28:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1460602 | Orgenesis Inc. | ORGS | Pharmaceutical Preparations (2834) | 980583166 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1726655 | Bruxelles De Libre Universite | Avenue F, Roosevelt, 50 Brussels C9 1050 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-11-13 | 204,396 | $1.83 | 817,584 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-15 | 204,396 | $1.83 | 613,188 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-17 | 204,396 | $1.83 | 408,792 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Reflects 12 for 1 reversed stock split effective November 16, 2017.
- The shares were sold for approximate aggregate purchase price of $373,554.